Home › Thoracic Cancer › District of Columbia › Washington
Thoracic Cancer clinical trials in Washington, DC
3 studies for Thoracic Cancer are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- Site 1001, Washington D.C.
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- Sibley Memorial Hospital, Washington D.C.
Erector Spinae Block for Thoracic Surgery
RecruitingPhase 4
- The George Washington University, Washington D.C.
Thoracic Cancer trials in other cities
- Houston, TX6 studies
- Boston, MA5 studies
- Durham, NC4 studies
- Arlington, VA4 studies
- Indianapolis, IN3 studies
- Baltimore, MD3 studies
- Nashville, TN3 studies
- New York City, NY3 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.